UMEDICA Laboratories is a finished-dose manufacturer based in India. It appears in 50 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India), EMA and FDA (GH), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 29 March 2024 as VAI. Customs aggregates show $42.3M of exports covering 1,398 molecules to 92 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Vapi, India | 3008460260 |
| Valsad, India | Not on file |
| vadodara 390 019vadodara, India | Not on file |
| vapivapi 396 195 valsad, India | Not on file |
| changodarah medabad 382 213, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 15 | None |
| MINSA (CR) | 8 | None |
| ZAMRA (ZM) | 6 | None |
| US FDA | 5 | 1 |
| TMDA (TZ) | 4 | None |
| BOMRA (BW) | 3 | None |
| CDSCO (India) | None | 4 |
| EMA | None | 1 |
| FDA (GH) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $12.8M | 70 |
| 2025 | Not reported | $42.3M | 92 |
| 2024 | Not reported | $37.2M | 44 |
| 2023 | Not reported | $21.6M | 46 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. UMEDICA Laboratories comes back tiered against every other supplier able to file there.
Start for free